Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
31 - 40 out of 68Page size: 10
  1. 2022
  2. Published

    Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence

    Rossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., Sadusky, T., Tandon, N., Tuttle, K. R., Wanner, C., Wilkens, K. G., Zoungas, S., Craig, J. C., Tunnicliffe, D. J., Tonelli, M. A., Cheung, M. & 2 others, Earley, A. & de Boer, I. H., 2022, In: Kidney International. 102, 5, p. 990-999 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial

    FIGARO DKD Investigators, F. D. I., 2022, In: Circulation. 145, 6, p. 437-447 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes

    Filippatos, G., Anker, S. D., Pitt, B., Rossing, Peter, Joseph, A., Kolkhof, P., Lambelet, M., Lawatscheck, R., Bakris, G. L., Ruilope, L. M. & Agarwal, R., 2022, In: JACC: Heart Failure. 10, 11, p. 860-870 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

    Rossing, Peter, Burgess, E., Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Ruilope, L. M., Gillard, P., Macisaac, R. J., Wainstein, J., Joseph, A., Brinker, M., Roessig, L., Scott, C., Bakris, G. L. & FIDELIO-DKD Investigators, F. I., 2022, In: Diabetes Care. 45, 4, p. 888-897 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

    Rossing, Peter, Anker, S. D., Filippatos, G., Pitt, B., Ruilope, L. M., Birkenfeld, A. L., McGill, J. B., Rosas, S. E., Joseph, A., Gebel, M., Roberts, L., Scheerer, M. F., Bakris, G. L. & Agarwal, R., 2022, In: Diabetes Care. 45, 12, p. 2991-2998 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy

    FIDELIO-DKD Investigators, F. I., 2022, In: Kidney International Reports. 7, 1, p. 36-45

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the FIDELIO-DKD trial

    Filippatos, G., Pitt, B., Agarwal, R., Farmakis, D., Ruilope, L. M., Rossing, Peter, Bauersachs, J., Mentz, R. J., Kolkhof, P., Scott, C., Joseph, A., Bakris, G. L., Anker, S. D. & FIDELIO-DKD Investigators, F. I., 2022, In: European Journal of Heart Failure. 24, 6, p. 996-1005 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Flexor Tendon Tenotomy Treatment of the Diabetic Foot: A Multicenter Randomized Controlled Trial

    Andersen, Jonas Askø, Rasmussen, A., Engberg, S., Bencke, J., Frimodt-Møller, M., Kirketerp-Møller, K. & Rossing, Peter, 2022, In: Diabetes Care. 45, 11, p. 2492-2500 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Genetic loci and prioritization of genes for kidney function decline derived from a meta-analysis of 62 longitudinal genome-wide association studies

    Gorski, M., Rasheed, H., Teumer, A., Thomas, L. F., Graham, S. E., Sveinbjornsson, G., Winkler, T. W., Günther, F., Stark, K. J., Chai, J-F., Tayo, B. O., Wuttke, M., Li, Y., Tin, A., Ahluwalia, T. S., Ärnlöv, J., Åsvold, B. O., Bakker, S. J. L., Banas, B., Bansal, N. & 29 others, Biggs, M. L., Biino, G., Böhnke, M., Boerwinkle, E., Bottinger, E. P., Brenner, H., Brumpton, B., Carroll, R. J., Chaker, L., Chalmers, J., Chee, M., Chee, M., Cheng, C., Chu, A. Y., Ciullo, M., Cocca, M., Cook, J. P., Coresh, J., Cusi, D., de Borst, M. H., Degenhardt, F., Eckardt, K., Endlich, K., Evans, M. K., Feitosa, M. F., Franke, A., Freitag-Wolf, S., Rossing, Peter & LifeLines Cohort Study, L. C. S., 2022, In: Kidney International. 102, 3, p. 624-639 16 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial

    FIDELIO-DKD Investigators, F. I., 2022, In: Journal of the American Society of Nephrology. 33, 1, p. 225-237 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 Next

ID: 12937790